In the past six months or so, the sudden outbreak of the novel coronavirus has caused great harm and impact on human health and normal life. It is worthy of recognition that the in vitro diagnostic reagents known as the “eyes” of doctors, especially high-throughput sequencing technology, nucleic acid detection, and antibody detection technology as supplementary diagnosis that have played an unprecedented role in control decision-making in the etiology confirmation, clinical laboratory diagnosis and prevention of this epidemic.
In order to exchange experience, and further comprehensively improve the ability and level of emergency response and handling of future public health emergencies. With the direct participation and strong support of the China Institute for Food and Drug Control, sponsored by the Biodiagnostic Technology Branch of the China Pharmaceutical Biotechnology Association, and undertaken by BACME Biotech with the theme of ‘ Implement accurate in vitro diagnostics and help scientific decision-making prevention and control ’, The 4th Forum on China Biological Diagnostics in Guiyang was held on September 17-19, 2020.
This forum invited leaders and front-line experts of prevention and control from the China Institute for Food and Drug Control, the Clinical Laboratory Center of the National Health Commission, and domestic experts and scholars engaged in in vitro diagnostic technology and product development and application to deliver keynote speeches. They also carry out direct communication and exchanges with participants by on-site interactive mode.
This conference carried out extensive and in-depth discussions and exchanges on the following hot topics. Including: interpretation of relevant policies and regulations for in vitro diagnostic reagents; key points of research and quality control of national reference materials for in vitro detection reagents for sudden acute infectious diseases; pathogenic detection and traceability of sudden acute infectious diseases; application and quality control of high-throughput sequencing; nucleic acid Application of detection and antibody detection technology in anti-epidemic practice and existing problems; preparation and thinking of key raw materials for diagnostic reagents; emergency detection capabilities and operational safety of clinical laboratories; pathogenic screening of traditional and new transfusion infectious diseases and blood transfusion safety, etc. .
Above of all, the speech was given by Mr.Jinlin Liu., chairman of board of BACME Biotech.
Speeches given by guests.
We would like to thank our colleagues in the field of biological diagnostics for coming to this conference, lets join hands in the continuous development and progress of our in vitro diagnostic technology and industry, and actively contribute wit and wisdom to help realize the national strategy of healthy China.
